These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6393386)

  • 1. [Atypical and controversial forms of chronic myeloid leukemia].
    Rodríguez Fernández JM; Martiń de Segovia JM
    Sangre (Barc); 1984; 29(4-B):629-44. PubMed ID: 6393386
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic granulocytic leukemia as a proliferative panmyelopathy of a clonal nature].
    Sánchez Fayos J; Lasierra Cirujeda J
    Sangre (Barc); 1984; 29(4-B):491-501. PubMed ID: 6393378
    [No Abstract]   [Full Text] [Related]  

  • 3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic granulocytic leukemia (Ph+): among yesterday's myeloproliferative syndromes, today's chronic myeloid leukemias, and tomorrow's mature-element monocellular myelopathies].
    Sánchez Fayos J; Prieto E; Chica Gullón E
    Sangre (Barc); 1998 Apr; 43(2):121-6. PubMed ID: 9656773
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cytodynamics of bone marrow precursors at different developmental stages of chronic granulocytic leukemia].
    Outeiriño J; Fernández Rañada JM; Sánchez Fayos J
    Sangre (Barc); 1984; 29(4-B):565-76. PubMed ID: 6595818
    [No Abstract]   [Full Text] [Related]  

  • 6. Naturally occurring feline leukemia: clinical, pathologic, and differential diagnostic features.
    Gilmore CE; Holzworth J
    J Am Vet Med Assoc; 1971 Mar; 158(6):Suppl 2:1013+. PubMed ID: 4932871
    [No Abstract]   [Full Text] [Related]  

  • 7. [FAB classification for diagnosis and therapy of leukemia].
    Tomonaga O
    Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):991-8. PubMed ID: 1328427
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments on feline leukemia: clinical and pathologic features, differential diagnosis.
    Schalm OW
    J Am Vet Med Assoc; 1971 Mar; 158(6):Suppl 2:1025+. PubMed ID: 5280564
    [No Abstract]   [Full Text] [Related]  

  • 9. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The lymphoid-like cells in blastic transformation of chronic myeloid leukemia].
    Lovisetto P; Guarnero A; Bonetto M; Biarese V
    Minerva Med; 1980 Mar; 71(8):527-39. PubMed ID: 6987552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chromosome findings in myeloproliferative diseases].
    Hellriegel KP
    Internist (Berl); 1968 Dec; 9(12):465-70. PubMed ID: 4891471
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis of chronic myelocytic leukemia].
    Krug K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):261-7. PubMed ID: 6168537
    [No Abstract]   [Full Text] [Related]  

  • 13. [Round table: Differentiation of human malignant lymphoid and myeloid cells].
    Nouv Rev Fr Hematol (1978); 1987; 29(2):129-39. PubMed ID: 3475675
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnostic importance of blood histamine levels in myeloproliferative diseases].
    Gingold N
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(6):541-6. PubMed ID: 6113673
    [No Abstract]   [Full Text] [Related]  

  • 15. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable persistence of leukemic progenitor cells in long-term CML and AML marrow cultures.
    Coulombel L; Eaves CJ; Dubé ID; Kalousek DK; Eaves AC
    Kroc Found Ser; 1984; 18():243-54. PubMed ID: 6597867
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis of myeloid hematologic malignancies: contributions of the 2001 World Health Organization (WHO) classification].
    Leymarie V; Galoisy AC; Falkenrodt A; Lessard M
    Ann Biol Clin (Paris); 2004; 62(5):513-20. PubMed ID: 15355801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How to assess a bone-marrow oligoblastosis in apparently normal subjects or those without a definite proliferative hemopathy].
    Woessner S; Sans-Sabrafen J; Lafuente R; Florensa L
    Sangre (Barc); 1984; 29(2):164-73. PubMed ID: 6382648
    [No Abstract]   [Full Text] [Related]  

  • 19. [Definition of "preleukemia" and differential diagnosis of early leukemic changes].
    Gross R; Hellriegel KP; Heller A
    Dtsch Med Wochenschr; 1973 Apr; 98(17):895-900. PubMed ID: 4571886
    [No Abstract]   [Full Text] [Related]  

  • 20. Transformation from committed progenitor to leukemia stem cells.
    Krivtsov AV; Feng Z; Armstrong SA
    Ann N Y Acad Sci; 2009 Sep; 1176():144-9. PubMed ID: 19796242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.